Hybridoma technology is a remarkable and indispensable tool for generating high-quality monoclonal antibodies. Hybridoma-derived monoclonal antibodies not only serve as powerful research and diagnostic reagents, but have also emerged as the most rapidly expanding class of therapeutic biologicals. In this chapter, an overview of hybridoma technology and the laboratory procedures used routinely for hybridoma production and antibody screening are presented, including characterization of peptide antibodies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-4939-2999-3_12 | DOI Listing |
Publication Analysis
Top Keywords
peptide antibodies
8
hybridoma technology
8
monoclonal antibodies
8
production screening
4
screening monoclonal
4
monoclonal peptide
4
antibodies
4
antibodies hybridoma
4
technology remarkable
4
remarkable indispensable
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!